Brentuximab vedotin in combination with or without donor lymphocyte infusion for patients with Hodgkin lymphoma after allogeneic stem cell transplantation
Research output: Contribution to journal › Article › peer-review
25Scopus
citations
Fingerprint
Dive into the research topics of 'Brentuximab vedotin in combination with or without donor lymphocyte infusion for patients with Hodgkin lymphoma after allogeneic stem cell transplantation'. Together they form a unique fingerprint.